Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Combined Asthma Self-Management and Depression Therapy for Older Adults With Asthma

Tests a combined asthma and depression program in older adults with both conditions.

Plain-language title generated from the registry record
Registry title: R34 Asthma Depression

Key facts

Where
New York, United StatesSee the site

Where in United States

  • Icahn School of Medicine Mount SinaiNew York, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Icahn School of Medicine at Mount Sinai
Trial code
NCT07895576
Record updated
26 October 2026
Original description
Depressive disorders are highly prevalent among older adults with asthma and are associated with poor asthma outcomes. The overall objective of this study is to integrate an asthma self-management support program that the research team previously developed with cognitive behavioral therapy (CBT) for adherence and depression for older adults with uncontrolled asthma and a comorbid depressive disorder. The research team will conduct a pilot randomized controlled trial to assess the feasibility and preliminary impact of the intervention on asthma and depression outcomes.Read full original descriptionShow less

Integrated Intervention for Depression and Asthma Self-management in Older Adults

Depressive disorders are highly prevalent among older adults with asthma and are associated with poor asthma outcomes. The overall objective of this study is to integrate an asthma self-management support program that the research team previously developed with cognitive behavioral therapy (CBT) for adherence and depression for older adults with uncontrolled asthma and a comorbid depressive disorder. The research team will conduct a pilot randomized controlled trial to assess the feasibility and preliminary impact of the intervention on asthma and depression outcomes.

Inclusion: English and Spanish speaking adults; Ages greater than or equal to 60 years; Have physician diagnosis of asthma for a year or more; Prescribed at least one asthma controller medication; Current diagnosis of major depressive disorder (MDD) or persistent depressive disorder (PDD).

Exclusion: Diagnosis of COPD or other chronic respiratory illness; History of smoking for greater than or equal to 15 years or packs throughout lifetime; Use of CBT in the past 12 months; Initiation or recent dose change of SSRI/SNRI within past 6 weeks.

ClinicalTrials.gov NCT07895576